BRIEF-Qiagen Q4 adjusted eps $0.15

* Qiagen NV - Qiagen reaffirms full-year 2017 outlook for 6-7 pct CER sales growth [Source]

Publication Date: Wednesday, 1 February 2017 at 23:27:07

Origin: reuters.com

Category: rbssHealthcareNews

Topics: Qiagen, growth, sales, for 6-7, outlook, full-year, reaffirms, adjusted, BRIEF-Qiagen

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/IcQbhR7-rZU/idUSASB0AY18

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22